Ubrelvy (ubrogepant) / Merck (MSD), AbbVie  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ubrelvy (ubrogepant) / AbbVie
NCT05654298: Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin

Completed
N/A
20
Europe
Sumatriptan, Ubrogepant
Universitaire Ziekenhuizen KU Leuven
Migraine
03/23
03/23
NCT06212661: Migraine Medication Effects on Urinary Symptoms

Enrolling by invitation
N/A
200
US
Ubrogepant, Ubrelvy, Rimegepant, Nurtec, Atogepant, Qulipta, Eptinezumab, Vyepti, Fremanezumab, Ajovy, Galcanezumab, Emgality, Erenumab, Aimovig, Botulinum toxin A, Botox
The Cleveland Clinic
Overactive Bladder, Bladder Pain Syndrome, Migraine Disorders, Overactive Bladder Syndrome, Overactive Detrusor, Migraine, Interstitial Cystitis
05/26
12/26
COURAGE II, NCT05653986: An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants

Completed
N/A
391
US
AbbVie
Migraine
08/24
08/24
NCT06692881: Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

Recruiting
N/A
167
Canada
AbbVie
Migraine
01/26
01/26
COBRA, NCT05827887: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

Active, not recruiting
N/A
200
RoW
AbbVie
Migraine
02/26
02/26
PHASES, NCT07310290: Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Not yet recruiting
N/A
189
NA
AbbVie
Migraine
03/27
03/27
NCT05158894: Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

Recruiting
N/A
1884
Canada, US
AbbVie
Migraine
01/36
01/36

Download Options